Ventyx Biosciences Inc.
VTYX | NASDAQ
$14
$0 (0.00%)
At close: Mar 6, 2026, 9:30 AM ET
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
PE Ratio | -1.11 | -0.75 | -15.87 | -11.95 | -37.53 | -9.20 |
PEG Ratio | 0.03 | -0.01 | -0.72 | -0.06 | 0.50 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.59 | 0.59 | 4.86 | 3.59 | -34.49 | -9.97 |
P/FCF Ratio | -1.14 | -0.87 | -17.37 | -25.73 | -170.66 | -15.57 |
P/OCF Ratio | -1.15 | -0.87 | -17.42 | -25.90 | -170.66 | -15.57 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.05 | 0 | n/a | -0.41 | -0.93 |
Quick Ratio | 17.97 | 11.87 | 20.21 | 21.41 | 0.17 | 0.55 |
Current Ratio | 17.97 | 11.87 | 20.21 | 21.41 | 0.17 | 0.55 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -678.25 | -19.69 | -28.63 |
Return on Equity | -53.19% | -79.11% | -30.64% | -30% | 91.91% | 108.36% |
Return on Assets | -48.86% | -69.49% | -29.19% | -28.73% | -11.5K% | -1.28K% |
Return on Invested Capital | -56.05% | -81.11% | -31.83% | -24.05% | 608.81% | 1.48K% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove VTYX